^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    SPOT-MAS 10 Test

    Company:
    Gene Solutions
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    2ms
    Gene Solutions Malaysia and National Cancer Society Malaysia Join Forces to Expand Access to Multi-Cancer Detection Through Early4Life Initiative ()
    ''Gene Solutions Malaysia, in collaboration with the National Cancer Society of Malaysia (NCSM), has expanded access to blood-based multi-cancer detection through the Early4Life initiative, reaching communities and frontline institutions across Malaysia with close to 300 SPOT-MAS 10 tests delivered to date.''
    Clinical
    |
    SPOT-MAS 10 Test
    3ms
    FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test (Yahoo Finance)
    ''Gene Solutions...today announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation to SPOT-MAS 10, its multi–omics blood test designed to detect cancer–associated signals.''
    Clinical
    |
    SPOT-MAS 10 Test
    9ms
    SPOT-MAS Launches in Taiwan: AI-Powered Multi-Cancer Early Detection Ushers in a New Era of Precision Medicine (PRNewswire)
    ''Gene Solutions...Taiwan joins this movement with the introduction of SPOT-MAS – an advanced screening solution developed by Gene Solutions, a global leader in precision oncology and genomics, in collaboration with local partner Gene Health. ''
    Launch • Clinical
    |
    SPOT-MAS 10 Test
    over1year
    Gene Solutions Leads the Way in Cancer Early Detection with Asia’s First Clinical Validated Multi-Cancer Blood Test (PRNewswire)
    "Gene Solutions...proudly announces a groundbreaking achievement in cancer early detection. The company's innovative SPOT-MAS test has become the first multi-cancer screening blood test in Asia to complete large prospective cohort validation, as published in BMC Medicine. This milestone marks a major advancement, enabling large-scale, non-invasive early detection."
    Clinical
    |
    SPOT-MAS 10 Test